CRISPR/CAS9 Gene Editing for Transthyretin (ATTR) Amyloidosis by Dr. Michael Maitland, Intellia – ASG Webinar – 6/12

Amyloidosis Support Groups webinar on ATTR amyloidosis from July 23, 2022. Led by ASG President Muriel Finkel, featured speaker Michael Maitland, MD, PhD, Sr. Director, Clinical Development, Intellia Therapeutics, talks about CRISPR/CAS9 Gene Editing for Transthyretin (ATTR) Amyloidosis

Stay Up To Date:

Receive the latest news and developments in treatment and care

Featured Resources

FAQs

1 The Core Members of an Amyloidosis Care Team ?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

2 What Treatment Options are Available for Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

3 How is Amyloidosis Diagnosed?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

4 What Specialists Are Involved in the Treatment of Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

Patient Care Center

CRISPR/CAS9 Gene Editing for Transthyretin (ATTR) Amyloidosis by Dr. Michael Maitland, Intellia – ASG Webinar – 6/12

Stay Up To Date:

Featured Resources

Caregiver Support : Taking care of yourself

Caregiver Support : Taking care of yourself

FAQs

Patient Affair Directory

Video Library